Drugs / Streptococcus salivarius M18
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06834815 | Nov 2024 → Feb 2025 | — | Ain Shams University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Streptococcus salivarius M18 | “probiotics (Streptococcus salivarius M18 and Lactobacillus reuteri)” NCT06834815 ↗ |
| Modality | Other / unclassified | “probiotics (Streptococcus salivarius M18 and Lactobacillus reuteri)” NCT06834815 ↗ |